Company intelligence / Profile preview

Adthera Bio

Birmingham, England, United Kingdom

Ownership: Private
Employees: ~11
Development stage: Other

Overview

Adthera Bio provides process development and GMP manufacturing services for autologous cell therapies and advanced therapy medicinal products. The company partners with biotechs and academic centers to bring novel cell and gene therapies to market in compliance with regulatory standards. No direct clinical results as it does not develop its own pipeline products.

Modalities: Cell therapyGene therapy
Industry: Contract Manufacturing Organization

Partnerships

Biotech companies developing cell/gene therapies (clients/partners)Academic centers developing ATMPs

Beyond the preview

Go deeper on Adthera Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Adthera Bio.

Explore the full profile